Kyntra Bio (KYNB) Interest & Investment Income (2015 - 2020)
Kyntra Bio (KYNB) posted Interest & Investment Income of $274000.0 for Q4 2020, down 81.35% sequentially from $1.5 million in Q3 2020, and down 91.02% YoY from $3.1 million in Q1 2020.
Kyntra Bio (KYNB) Interest & Investment Income (2015 - 2020) Analysis & Trends
Kyntra Bio has reported Interest & Investment Income for 6 years, with the latest figure at $274000.0 in Q4 2020.
- Quarterly Interest & Investment Income fell 91.02% year-over-year to $274000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $5.6 million (down 64.29% YoY) and the FY2020 annual result came in at $5.6 million, down 64.28% from the prior year.
- Interest & Investment Income declined to $274000.0 in Q4 2020 per KYNB's latest filing, from $1.5 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $4.2 million in Q3 2019 and troughed at $129000.0 in Q2 2016.
- A 5-year average of $2.1 million and a median of $1.8 million in 2018 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2017 and 2020: Interest & Investment Income jumped 1582.03% in 2017, then sank 91.02% in 2020.
- Over 5 years, Interest & Investment Income stood at $217000.0 in 2016, then soared by 1582.03% to $3.6 million in 2017, then gained by 3.34% to $3.8 million in 2018, then decreased by 19.09% to $3.1 million in 2019, then tumbled by 91.02% to $274000.0 in 2020.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $274000.0, $1.5 million, and $644000.0 for Q4 2020, Q3 2020, and Q2 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Kyntra Bio | 30.42 Mn | 30.42 Mn | 1.47 Mn | 29.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 274,000.00 |
| Sep 30, 2020 | 1.47 Mn |
| Jun 30, 2020 | 644,000.00 |
| Mar 31, 2020 | 3.17 Mn |
| Dec 31, 2019 | 3.05 Mn |
| Sep 30, 2019 | 4.19 Mn |
| Jun 30, 2019 | 4.13 Mn |
| Mar 31, 2019 | 4.18 Mn |
| Dec 31, 2018 | 3.77 Mn |
| Sep 30, 2018 | 3.08 Mn |
| Jun 30, 2018 | 2.65 Mn |
| Mar 31, 2018 | 2.07 Mn |
| Dec 31, 2017 | 3.65 Mn |
| Sep 30, 2017 | 1.11 Mn |
| Jun 30, 2017 | 1.03 Mn |
| Mar 31, 2017 | 645,000.00 |
| Dec 31, 2016 | 217,000.00 |
| Sep 30, 2016 | 866,000.00 |
| Jun 30, 2016 | 129,000.00 |
| Mar 31, 2016 | 1.42 Mn |